PathGen Top 3 start-up XTC 2021 Indonesia

by | May 3, 2021 | News & Events

PathGen is proud to be among the top 3 start-up that will represent Indonesia in the world largest social innovation start-up forum and competition, Extreme Tech Challenge that will be held on 22 July 2021 in California, USA (online). The selection process for regional Indonesia was held early April 2021 and the demo and judging for the top 10 finalists was held in 27 April 2021. Inspired by the United Nations 17 Sustainable Development Goals (SDGs), the XTC supports and showcases the innovators harnessing the power of technology to address the greatest challenges facing humanity and our planet.

Established in early 2020, PathGen vision is to achieve global equity in precision medicine of cancers and other diseases by providing low-cost molecular diagnostics test and digital pathology and engaging in capacity building through knowledge exchange with the global partners. PathGen CEO, Susanti, has unique insight as a cancer survivor herself thus given her important perspectives into the field allowing her to form research and development strategies that are particularly relevant for patients and those living beyond cancer.

PathGen products are ColoMelt-Dx (colorectal cancer diagnostics) and INDiPath ViuMe (Artificial Intelligence digital pathology software and hardware). We are supported by prominent scientists from UK, Australia and Indonesia including Dr. Ahmad Utomo (Yarsi), Dr. Wien Kusharyoto and Mr. Asep Ridwanuloh (LIPI), Prof Aru W Sudoyo (Yayasan Kanker Indonesia), Dr. Ines Atmosukarto (Australia National University), Prof Ilyas (University of Nottingham and Prof. Ian Tomlinson (Cancer Research UK Edinburgh Centre).

PathGen is an innovation-based start-up that was initiated by NICCRAT consortium (Nottingham-Indonesia Collaboration for Clinical Research and Training), established in 2019 and led by Dr. Susanti and Prof. Mohammad Ilyas (University of Nottingham) to foster the academics partnership with Indonesian institutions, including Indonesia Institute of Sciences (LIPI), Bio Farma, and many medicals schools including in Univeristas Gadjah Mada, Universitas Indonesia, Universitas Yarsi, Universitas Sriwijaya, Universitas Hassanudin, Universitas Riau, and Universitas Muhammadiyah Purwokerto